BSX Boston Scientific
NYSE · SEC CIK 885725 · EDGAR
- Bought, last 12 months
- $10.04M 8 purchases by 5 insiders
- Sold, last 12 months
- $29.27M 6 sales by 4 insiders
- Filings on record
- 526 since 2021-07-06, latest 2026-09-03 16:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| Zane Ellen M | Dir | — | $2.57M |
| Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| LUDWIG EDWARD J | Dir | $430.3K | — |
| Habiger David C | Dir | $407.9K | — |
| Morano Susan E | Dir | $100.4K | — |
| Pegus Cheryl | Dir | $100.0K | — |
| O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Transactions 847
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-22 | 2022-02-17+ | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $42.70 | -3,677 | 270.8K | -1% | -$157.0K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +8,289 | 270.8K | +3% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | F - Tax | $42.70 | -2,177 | 31.9K | -6% | -$93.0K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | M - OptEx | $0.00 | +5,205 | 34.2K | +18% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +34.6K | 2.11M | +2% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $42.70 | -15.4K | 2.11M | -0.7% | -$656.0K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,741 | 31.7K | +6% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $42.72 | -546 | 31.5K | -2% | -$23.3K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Mackey Edward F | EVP, Ops | M - OptEx | $0.00 | +28.8K | 58.2K | +98% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Mackey Edward F | EVP, Ops | F - Tax | $42.57 | -11.1K | 34.4K | -24% | -$474.3K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Carruthers Wendy | SVP, Human Resources | F - Tax | $42.70 | -1,205 | 161.2K | -0.7% | -$51.5K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Carruthers Wendy | SVP, Human Resources | M - OptEx | $0.00 | +4,103 | 161.8K | +3% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | M - OptEx | $0.00 | +2,612 | 24.7K | +12% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | F - Tax | $42.71 | -768 | 24.4K | -3% | -$32.8K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +7,872 | 214.3K | +4% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $42.70 | -3,885 | 212.2K | -2% | -$165.9K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Pierce David A | EVP Pres MedSurg | F - Tax | $42.71 | -1,763 | 4,238 | -29% | -$75.3K |
| D | 2022-02-22 | 2022-02-18 | BSX | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $42.88 | -2,354 | 1,884 | -56% | -$100.9K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +6,001 | 5,022 | New | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +2,453 | 14.3K | +21% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $42.71 | -1,223 | 13.5K | -8% | -$52.2K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | M - OptEx | $0.00 | +2,695 | 22.1K | +14% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | F - Tax | $42.72 | -821 | 21.0K | -4% | -$35.1K |
| D | 2022-02-17 | 2022-02-15 | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | M - OptEx | $0.00 | +1,661 | 173.1K | +1.0% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | F - Tax | $44.01 | -575 | 172.5K | -0.3% | -$25.3K |
| D | 2022-02-17 | 2022-02-15 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | F - Tax | $44.01 | -780 | 30.2K | -3% | -$34.3K |
| D | 2022-02-17 | 2022-02-15 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | M - OptEx | $0.00 | +1,846 | 31.0K | +6% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $44.01 | -1,219 | 275.3K | -0.4% | -$53.6K |
| DM | 2022-02-17 | 2022-02-15+ | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $4.68 | +16.3K | 278.4K | +6% | +$76.5K |
| DM | 2022-02-17 | 2022-02-15+ | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $43.60 | -21.3K | 266.2K | -7% | -$929.7K |
| D | 2022-02-17 | 2022-02-15 | BSX | Pierce David A | EVP Pres MedSurg | F - Tax | $44.01 | -813 | 1,956 | -29% | -$35.8K |
| D | 2022-02-17 | 2022-02-15 | BSX | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +2,769 | 2,769 | New | $0 |
| D | 2022-02-17 | 2022-02-16 | BSX | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $43.81 | -1,956 | 0 | -100% | -$85.7K |
| D | 2022-02-17 | 2022-02-15 | BSX | Mackey Edward F | EVP, Ops | F - Tax | $44.01 | -813 | 32.4K | -2% | -$35.8K |
| D | 2022-02-17 | 2022-02-15 | BSX | Mackey Edward F | EVP, Ops | M - OptEx | $0.00 | +2,769 | 33.2K | +9% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Monson Jonathan | VP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +738 | 29.5K | +3% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Monson Jonathan | VP, CAO, Gbl Ctrl | F - Tax | $44.01 | -259 | 29.2K | -0.9% | -$11.4K |
| D | 2022-02-17 | 2022-02-15 | BSX | Carruthers Wendy | SVP, Human Resources | M - OptEx | $0.00 | +1,661 | 160.1K | +1% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Carruthers Wendy | SVP, Human Resources | F - Tax | $44.01 | -488 | 159.6K | -0.3% | -$21.5K |
| D | 2022-02-17 | 2022-02-15 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +1,292 | 13.6K | +11% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $44.01 | -707 | 12.8K | -5% | -$31.1K |
| D | 2022-02-17 | 2022-02-15 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | M - OptEx | $0.00 | +923 | 22.8K | +4% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | F - Tax | $44.01 | -272 | 22.5K | -1% | -$12.0K |
| D | 2022-02-17 | 2022-02-15 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $44.01 | -8,186 | 2.09M | -0.4% | -$360.3K |
| D | 2022-02-17 | 2022-02-15 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +18.5K | 2.10M | +0.9% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | M - OptEx | $0.00 | +1,108 | 20.2K | +6% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | F - Tax | $44.01 | -388 | 19.9K | -2% | -$17.1K |
| D | 2022-02-17 | 2022-02-15 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $44.01 | -622 | 134.6K | -0.5% | -$27.4K |
| D | 2022-02-17 | 2022-02-15 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,030 | 135.2K | +2% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +923 | 30.6K | +3% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $44.01 | -323 | 30.3K | -1% | -$14.2K |
| D | 2022-02-17 | 2022-02-08 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | G - Gift | $0.00 | -1,767 | 32.7K | -5% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | M - OptEx | $0.00 | +1,200 | 33.9K | +4% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | F - Tax | $44.01 | -368 | 33.6K | -1% | -$16.2K |
| D | 2022-02-17 | 2022-02-07 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | G - Gift | $0.00 | -2,780 | 207.8K | -1% | $0 |
| DI | 2022-02-17 | 2022-02-07 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | G - Gift | $0.00 | +1,390 | 7,428 | +23% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $44.01 | -2,278 | 210.1K | -1% | -$100.3K |
| D | 2022-02-17 | 2022-02-15 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +4,614 | 212.4K | +2% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +1,108 | 31.9K | +4% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $44.01 | -326 | 31.6K | -1% | -$14.3K |
| D | 2022-02-17 | 2022-02-15 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $44.01 | -1,038 | 89.6K | -1% | -$45.7K |
| D | 2022-02-17 | 2022-02-15 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,846 | 90.7K | +2% | $0 |
| 2022-02-08 | 2022-02-07 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | S - Sale | $43.20 | -13.2K | 34.5K | -28% | -$568.8K | |
| D | 2022-02-02 | 2022-02-01 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +3,131 | 31.8K | +11% | $0 |
| D | 2022-02-02 | 2022-02-01 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $43.50 | -919 | 30.8K | -3% | -$40.0K |
| 2022-01-05 | 2022-01-04 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $43.54 | -6,840 | 133.2K | -5% | -$297.8K | |
| 2022-01-05 | 2022-01-04 | BSX | Pierce David A | EVP Pres MedSurg | S - Sale | $43.54 | -6,161 | 0 | -100% | -$268.2K | |
| 2022-01-04 | 2022-01-03 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | S - Sale | $42.59 | -700 | 12.1K | -5% | -$29.8K | |
| D | 2022-01-03 | 2022-01-01 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | M - OptEx | $0.00 | +3,929 | 49.1K | +9% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | F - Tax | $42.48 | -1,382 | 47.7K | -3% | -$58.7K |
| D | 2022-01-03 | 2022-01-01 | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | M - OptEx | $0.00 | +6,175 | 173.8K | +4% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | F - Tax | $42.48 | -2,346 | 171.4K | -1% | -$99.7K |
| D | 2022-01-03 | 2022-01-01 | BSX | Mackey Edward F | EVP, Ops | F - Tax | $42.48 | -3,068 | 30.5K | -9% | -$130.3K |
| D | 2022-01-03 | 2022-01-01 | BSX | Mackey Edward F | EVP, Ops | M - OptEx | $0.00 | +9,824 | 33.5K | +41% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +13.2K | 276.4K | +5% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $42.48 | -4,057 | 272.4K | -1% | -$172.3K |
| D | 2022-01-03 | 2022-01-01 | BSX | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +8,982 | 8,982 | New | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Pierce David A | EVP Pres MedSurg | F - Tax | $42.48 | -2,821 | 6,161 | -31% | -$119.8K |
| D | 2022-01-03 | 2022-01-01 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | F - Tax | $42.48 | -2,766 | 29.2K | -9% | -$117.5K |
| D | 2022-01-03 | 2022-01-01 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | M - OptEx | $0.00 | +6,175 | 31.9K | +24% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Carruthers Wendy | SVP, Human Resources | M - OptEx | $0.00 | +5,614 | 160.2K | +4% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Carruthers Wendy | SVP, Human Resources | F - Tax | $42.48 | -1,832 | 158.4K | -1% | -$77.8K |
| D | 2022-01-03 | 2022-01-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +60.6K | 2.11M | +3% | $0 |
| D | 2022-01-03 | 2021-11-12 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -34.9K | 2.05M | -2% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $42.48 | -23.5K | 2.08M | -1% | -$1.00M |
| D | 2022-01-03 | 2022-01-01 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +10.1K | 143.3K | +8% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $42.48 | -3,265 | 140.0K | -2% | -$138.7K |
| D | 2022-01-03 | 2022-01-01 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +14.0K | 217.6K | +7% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $42.48 | -7,099 | 210.5K | -3% | -$301.6K |
| D | 2022-01-03 | 2022-01-01 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | F - Tax | $42.48 | -1,179 | 21.9K | -5% | -$50.1K |
| D | 2022-01-03 | 2022-01-01 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | M - OptEx | $0.00 | +3,367 | 23.1K | +17% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +3,649 | 29.9K | +14% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $42.48 | -1,265 | 28.6K | -4% | -$53.7K |
| D | 2022-01-03 | 2022-01-01 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +6,175 | 92.3K | +7% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $42.48 | -3,472 | 88.8K | -4% | -$147.5K |
| 2021-12-29 | 2021-12-28 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | S - Sale | $43.21 | -7,018 | 26.2K | -21% | -$303.2K | |
| D | 2021-12-21 | 2021-12-20 | BSX | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $39.90 | -50.0K | 0 | -100% | -$1.99M |
| DM | 2021-12-21 | 2021-12-20 | BSX | Pierce David A | EVP Pres MedSurg | M - OptEx | $7.27 | +47.9K | 50.0K | +2,330% | +$348.7K |
| 2021-12-16 | 2021-12-15 | BSX | Carruthers Wendy | SVP, Human Resources | S - Sale | $40.83 | -3,321 | 154.6K | -2% | -$135.6K | |
| DM | 2021-12-06 | 2021-08-30+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | G - Gift | $0.00 | -318 | 132.9K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations